Biologics Supplier for Orthopedic Practices in Virginia Beach, VA

Vendor qualification for orthopedic accounts

Orthopedic practices and ambulatory surgery centers typically qualify a biologics distributor the same way they qualify any tissue or pharmaceutical vendor: confirming the sourcing pathway, requesting lot-specific documentation, and verifying that ordering is restricted to licensed professionals. Precision Biologics structures its account process around those expectations rather than a sales pitch.

A qualification review usually starts before the first order, with staff requesting a sample certificate of analysis, a donor eligibility summary format, and an explanation of how lot numbers are tracked from receipt through use in the patient record.

• Certificate of analysis
• Donor eligibility summary
• Lot release record

NPI-verified ordering

Every account is tied to a National Provider Identifier. A practice submits its NPI during setup, and orders are released only once that number is confirmed against the NPPES registry. This applies to solo orthopedic surgeons and multi-provider surgery centers alike.

Group practices with several associates can register additional authorized ordering contacts under the same account, with the NPI of the supervising or ordering physician attached to each purchase record.

Receiving shipments in the Southeast

Cryopreserved Wharton's jelly products are shipped overnight on dry ice in validated containers and are stored at -80 degrees Celsius on arrival. Practices in the Virginia Beach-Norfolk metro receive shipments on the same overnight basis as any other verified account; there is no regional exception to the cold chain.

Lyophilized formats do not require the same cryogenic handling and are stored and reconstituted according to the product insert that accompanies each lot.

Confirming your own regulatory posture

Whether a specific intended use for a Wharton's jelly or exosome product fits within an orthopedic practice's existing regulatory framework is a determination the practice and its counsel make, not something Precision Biologics decides on a clinic's behalf. We recommend verifying your position with the Virginia Board of Medicine and with legal counsel before adding any new product line to a surgery center's protocol.

Precision Biologics supports that review by making registration and licensure documentation, lot-level records, and supplier characterization data available to verified accounts on request, and by offering physician-level calls focused on documentation rather than clinical guidance.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.